Quantifying Agglomerate-to-Wall Impaction in Dry Powder Inhalers

Pharm Res. 2023 Jan;40(1):307-319. doi: 10.1007/s11095-022-03446-0. Epub 2022 Dec 5.

Abstract

Purpose: The probability of agglomerate-to-wall collision was quantified using a unique image processing technique applied to high-speed microscopic images. The study aimed to investigate the effects of flow rate and particle size on the percentage of colliding agglomerates detected within an in-house powder dispersion device.

Method: The device consists of a swirl chamber and two tangential inlets in various configurations, designed to emulate the geometric features of commercial devices such as the Aerolizer® and Osmohaler®. The test cases were conducted with constant flow rates of 30 SLPM and 60 SLPM. Four powder samples were tested, including carrier Respitose® SV010 (median volume diameter 104 µm, span 1.7) and mannitol of three constituent primary particle sizes (3 µm, 5 µm and 7 µm; span 1.6 - 1.9).

Results: At the lower flow rate of 30 SLPM, collision frequencies were significantly different between powders of different constituent particle sizes, but the effects of powder properties diminished on increasing the flow rate to 60 SLPM. At the higher flow rate, all powders experienced a significant increase in the proportion of colliding particles.

Conclusion: Analysis of collision events showed that the probability of collision for each agglomerate increased with agglomerate diameter and velocity. Experimental data of agglomerate-to-wall collision were utilised to develop a logistic regression model that can accurately predict collisions with various powders and flow rates.

Keywords: dispersion mechanisms; dry powder inhalers; high-speed imaging.

MeSH terms

  • Administration, Inhalation
  • Aerosols
  • Dry Powder Inhalers*
  • Mannitol*
  • Particle Size
  • Powders

Substances

  • Aerosols
  • Powders
  • Mannitol